Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
messenger ribonucleic acid mpox vaccine
- Development stage
- Preclinical
- Lead developer
- EastGate Biotech
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
01
Overview
The messenger ribonucleic acid (mRNA) mpox vaccine is an investigational vaccine candidate developed by EastGate Financial for the prevention of mpox (formerly known as monkeypox). This vaccine utilizes mRNA technology to deliver genetic instructions to host cells, prompting them to synthesize specific antigens associated with the mpox virus. These antigens then trigger a protective immune response, including the production of antibodies and the activation of T cells, to defend against future infection. The program was identified through corporate communications from EastGate Financial and is currently in the early stages of development.
- Other names
- mRNA mpox vaccinemessenger ribonucleic acid mpox vaccine-EastGate Financial-mRNA vaccine-Mpox (Monkeypox)
02
Targets
OPXV MV/EEV antigens (Orthopoxvirus mature virion and extracellular enveloped virion surface antigens)
Beyond the preview
Go deeper on messenger ribonucleic acid mpox vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on messenger ribonucleic acid mpox vaccine.